Naive CD8+ T cells, after activation by APC and recognition by the TCR of peptide-specific MHC-I complexes, activate and differentiate into effector CTLs, which are then capable of targeting and killing cells (such as infected cells and cancer cells) and secreting protective cytokines [73]. Here, CD8A is linked to cancer.